Degradable CRISPR/Cas9 nanosystem activated by NIR-II light targets genome editing of PD-L1 and metabolic modulation for enhanced antitumor immunity
Xiaoyi Zhao, Kangli Guo, Kai Zhang, Xiaokang Ding, Nana Zhao, Fu‐Jian Xu, Fu‐Jian Xu
Topics & Concepts
CRISPRCas9Genome editingTumor microenvironmentAcquired immune systemImmunogenic cell deathPhotothermal therapyCancer researchImmune systemImmunotherapyNanocarriersChemistryCell biologyBiologyNanotechnologyBiochemistryMaterials scienceImmunologyDrug deliveryGeneOrganic chemistryNanoplatforms for cancer theranosticsCRISPR and Genetic EngineeringImmunotherapy and Immune Responses